Product Benefits
Legend Sampling to Physicians and Alternatives to Sampling
Controlled Substance Sampling to Physicians and Alternatives to Sampling
Wholesale Distribution
Pedigree Requirements
Mid-level Practitioner Sampling Authority
Porzio Compliance Digest
Porzio Licensing Services
Porzio AggregateSpendID℠
Porzio Compliance Modules
Porzio Significant Loss Threshold Assurance
ePorzio
Porzio Other Services
Our People
Recent Articles
Events
News
Careers
Home
Products & Services
About Us
Contact Us
Subscriber Login
GoToMeeting
Blog
About Us
Our People
Recent Articles
Events
News
Careers
About Us
>
Recent Articles
Navigating Through the Disparities of State Marketing Tracking and Disclosure Laws
Thought Leadership Sales and Marketing Compliance
by Garineh S. Dovletian and Christopher R. Corallo
A growing number of
states are requiring pharmaceutical companies to track their annual expenditures relating to marketing activities
to comply with annual spending limits and state reporting requirements. Since the passage of
Minnesota's marketing disclosure law in 1993, several other states such as California, Maine, Vermont, West Virginia, as well as the District of Columbia, have enacted laws imposing varying expense limitations and disclosure requirements on companies that market prescription products in those states
. Additionally, currently there are bills pending in approximately nine states that, if passed, would impose further expense tracking or disclosure requirements on companies.
Read entire article – click here
Request more information
or call 973.538.1690
<< Back
© Porzio Pharmaceutical Services, LLC